Opus Genetics - M&A Summary and Business Overview

Life ScienceCompany

Opus Genetics M&A Summary

Opus Genetics has acquired 1 company, including 1 in the last 5 years.

Opus Genetics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Opus Genetics Business Overview

Where is Opus Genetics headquartered?

Opus Genetics is headquartered in Farmington Hills, Michigan.

What is Opus Genetics’ revenue?

Opus Genetics disclosed revenue of 19M USD for 2023 and 40M USD for 2022.

How many employees does Opus Genetics have?

Opus Genetics has 14 employees.

What sector is Opus Genetics in?

Opus Genetics is a life science company.

When was Opus Genetics founded?

Opus Genetics was founded in 2018.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 2

Opus Genetics

Opus Genetics, Inc.

37000 Grand River Avenue, Suite 120,
Farmington Hills, Michigan 48335
United States,
(248) 681-9815
www.opusgtx.com

Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Opus Genetics' lead product candidate, Nyxol Eye Drops, is a once-daily preservative-free eye drop formulation of phentolamine mesylate, a non-selective alpha-1 and alpha-2 adrenergic antagonist designed to reduce pupil size and improve visual acuity. Opus Genetics was founded in 2018 and is based in Farmington Hills, Michigan.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # - 1 - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Ocuphire Pharma, Inc. (old) 2020-06-17 - Merger
Farmington Hills, Michigan
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
United States 1 - - -
  Michigan 1 - - -
Total 1 - - -

Top M&A Advisors

Financial Deals
Oppenheimer & Co.
1
Legal Deals
Hogan Lovells
1

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.